Outlook Therapeutics, Inc. (OTLK)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 10:33AM EDT. Market open.
| Previous Close | 8.61 |
| Open | 8.79 |
| Bid | 8.31 x 100 |
| Ask | 8.58 x 100 |
| Day's Range | 8.12 - 8.79 |
| 52 Week Range | 4.00 - 40.60 |
| Volume | |
| Avg. Volume | 653,283 |
| Market Cap | 188.868M |
| Beta (5Y Monthly) | 0.19 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
Insiders are Piling into These 10 Healthcare Stocks in 2024
In this article, we will take a detailed look at Insiders are Piling into These 10 Healthcare Stocks in 2024. For a quick overview of such stocks, read our article Insiders are Piling into These 5 Healthcare Stocks in 2024. Healthcare investors were nervous when 2024 started, since election years usually don’t bode well for healthcare stocks. But […]
- GuruFocus.com
Outlook Therapeutics Inc (OTLK) Reports Q1 Fiscal 2024 Results and Strategic Developments
Financial and Corporate Milestones Highlighted Amidst Clinical Progress
- Zacks
Outlook (OTLK) Surges 31% on Regulatory Update for AMD Study
Outlook (OTLK) stock rises after aligning with the FDA regarding the protocols of a non-inferiority study of ONS-5010 for AMD. The study is set to become the basis for BLA resubmission by 2024-end.
© 2024 Yahoo. All rights reserved.